Recent advances in diaper dermatitis: Etiology and treatment

Pediatric Health

Volumn 3, Issue 1, 2009, Pages 81-98

  Visscher, Marty O ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Candidiasis; Diaper dermatitis; Epidermis; Erythema; Infant; Irritant dermatitis; Rash; Skin barrier; Skin protectant; Stratum corneum

Indexed keywords

BETAMETHASONE DIPROPIONATE; CICLOPIROX; CLOTRIMAZOLE; NYSTATIN; OCTADECANOL; PETROLATUM; TRIAMCINOLONE; ZINC OXIDE;

CANDIDIASIS; DESQUAMATION; DIAPER DERMATITIS; DISEASE PREDISPOSITION; DRY SKIN; ENVIRONMENTAL EXPOSURE; ERYTHEMA; HIGH RISK PATIENT; HUMAN; HYDRATION; HYGIENE; INCIDENCE; IRRITANT DERMATITIS; MYCOSIS; PH; PREMATURITY; RASH; REVIEW; SKIN PH; SKIN ULCER; STAPHYLOCOCCUS INFECTION;

EID: 70349790444     PISSN: 17455111     EISSN: None     Source Type: Journal    
DOI: 10.2217/17455111.3.1.81     Document Type: Review

References (162)

1. Hoath SB, Visscher M, Heaton C, Neale H: Skin science and the future of dermatology. J. Cutan. Med. Surg. 3(1), 2-8 (1998).
2. Boulais N, Misery L: The epidermis: a sensory tissue. Eur. J. Dermatol. 18(2), 119-127 (2008).
3. Denda M, Nakatani M, Ikeyama K, Tsutsumi M, Denda S: Epidermal keratinocytes as the forefront of the sensory system. Exp. Dermatol. 16(3), 157-161 (2007).
4. Elias PM: The skin barrier as an innate immune element. Semin. Immunopathol. 29(1), 3-14 (2007).
5. Schmid-Wendtner MH, Korting HC: The pH of the skin surface and its impact on the barrier function. Skin Pharmacol. Physiol. 19(6), 296-302 (2006).
6. Rippke F, Schreiner V, Schwanitz HJ: The acidic milieu of the horny layer: new findings on the physiology and pathophysiology of skin pH. Am. J. Clin. Dermatol. 3(4), 261-272 (2002).
7. Mauro T, Holleran WM, Grayson S et al.: Barrier recovery is impeded at neutral pH, independent of ionic effects: implications for extracellular lipid processing. Arch. Dermatol. Res. 290(4), 215-222 (1998).
8. Cunico RL, Maibach HI, Khan H, Bloom E: Skin barrier properties in the newborn: transepidermal water loss and carbon dioxide emission rates. Biol. Neonate 32(3-4), 177-182 (1977).
9. Yosipovitch G, Maayan-Metzger A, Merlob P, Sirota L: Skin barrier properties in different body areas in neonates. Pediatrics 106(1 Pt 1), 105-108 (2000).
10. Visscher MO, Chatterjee R, Munson KA, Pickens WL, Hoath SB: Changes in diapered and nondiapered infant skin over the first month of life. Pediatr. Dermatol. 17(1), 45-51 (2000).
11. Visscher M: Infant skin research. Presented at: The 2nd Annual Joint Meeting of the International Society of Bioengineering and the Skin and the International Society for Skin Imaging. Philadelphia, PA, USA, 29 September-1 October 2005.
12. Hoeger PH, Enzmann CC: Skin physiology of the neonate and young infant: a prospective study of functional skin parameters during early infancy. Pediatr. Dermatol. 19(3), 256-262. (2002).
13. Visscher MO, Chatterjee R, Munson KA, Pickens WL, Hoath SB: Changes in diapered and nondiapered infant skin over the ?rst month of life. Pediatr. Dermatol. 17(1), 45-51 (2000).
14. Yosipovitch G, Maayan-Metzger A, Merlob P, Sirota L: Skin barrier properties in different body areas in neonates. Pediatrics 106(1 Pt 1), 105-108 (2000).
15. Walker VP, Akinbi HT, Meinzen-Derr J, Narendran V, Visscher M, Hoath SB: Host defense proteins on the surface of neonatal skin: implications for innate immunity. J. Pediatr. 152(6), 777-781 (2008).
16. Pickens WL, Warner RR, Boissy YL, Boissy RE, Hoath SB: Characterization of vernix caseosa: water content, morphology, and elemental analysis. J. Invest. Dermatol. 115(5), 875-881 (2000).
17. Hardman MJ, Sisi P, Banbury DN, Byrne C: Patterned acquisition of skin barrier function during development. Development 125(8), 1541-1552 (1998).
18. Akinbi HT, Narendran V, Pass AK, Markart P, Hoath SB: Host defense proteins in vernix caseosa and amniotic fluid. Am. J. Obstet. Gynecol. 191(6), 2090-2096 (2004).
19. Visscher MO, Narendran V, Pickens WL et al.: Vernix caseosa in neonatal adaptation. J. Perinatol. 25(7), 440-446 (2005).
20. Cartlidge P: The epidermal barrier. Semin. Neonatol. 5(4), 273-280 (2000).
21. Evans NJ, Rutter N: Development of the epidermis in the newborn. Biol. Neonate 49(2), 74-80 (1986).
22. Agren J, Sjors G, Sedin G: Transepidermal water loss in infants born at 24 and 25 weeks of gestation. Acta Paediatr. 87(11), 1185-1190 (1998).
23. Harpin VA, Rutter N: Barrier properties of the newborn infant's skin. J. Pediatr. 102(3), 419-425. (1983).
24. Kalia YN, Nonato LB, Lund CH, Guy RH: Development of skin barrier function in premature infants. J. Invest. Dermatol. 111(2), 320-326 (1998).
25. Nonato LB, Lund CH, Kalia YN, Guy RH: Transepidermal water loss in 24 and 25 weeks gestational age infants. Acta Paediatr. 89(6), 747-748 (2000).
26. Denda M, Sato J, Tsuchiya T, Elias PM, Feingold KR: Low humidity stimulates epidermal DNA synthesis and amplifies the hyperproliferative response to barrier disruption: implication for easonal exacerbations of inflammatory dermatoses. J. Invest. Dermatol. 111(5), 873-878 (1998).
27. Rawlings AV, Scott IR, Harding CR, Bowser PA: Stratum corneum moisturization at the molecular level. J. Invest. Dermatol. 103(5), 731-741 (1994).
28. Scott IR, Harding CR: Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev. Biol. 115(1), 84-92 (1986).
29. Fox C, Nelson D, Wareham J: The timing of skin acidification in very low birth weight infants. J. Perinatol. 18(4), 272-275 (1998).
30. Visscher M, Hoath, SB: Diaper dermatitis. In: Irritant Dermatitis. Chew A (Ed.). Springer, Berlin, Germany, 37-51 (2006).
31. Yung-Weng W, Ying-Ju C: A preliminary study of bottom care effects on premature infants' heart rate and oxygen saturation. J. Nurs. Res. 12(2), 161-168 (2004).
32. Jordan WE, Lawson KD, Berg RW, Franxman JJ, Marrer AM: Diaper dermatitis: frequency and severity among a general infant population. Pediatr. Dermatol. 3(3), 198-207 (1986).
33. Berg RW: Etiology and pathophysiology of diaper dermatitis. Adv. Dermatol. 3, 75-98 (1988).
34. Akin F, Spraker M, Aly R, Leyden J, Raynor W, Landin W: Effects of breathable disposable diapers: reduced prevalence of Candida and common diaper dermatitis. Pediatr. Dermatol. 18(4), 282-290 (2001).
35. Hayakawa R, Matsunaga K: Common conditions and factors associated with diaper dermatitis. Pediatrician 14(Suppl. 1), 18-20 (1987).
36. Philipp R, Hughes A, Golding J: Getting to the bottom of nappy rash: ALSPAC survey team. Avon Longitudinal Study of Pregnancy and Childhood. Br. J. Gen. Pract. 47(421), 493-497 (1997).
37. Ward DB, Fleischer AB Jr, Feldman SR, Krowchuk DP: Characterization of diaper dermatitis in the United States. Arch. Pediatr. Adolesc. Med. 154(9), 943-946 (2000).
38. Adalat S, Wall D, Goodyear H: Diaper dermatitis-frequency and contributory factors in hospital attending children. Pediatr. Dermatol. 24(5), 483-488 (2007).
39. Noonan C, Quigley S, Curley MA: Skin integrity in hospitalized infants and children: a prevalence survey. J. Pediatr. Nurs. 21(6), 445-453 (2006).
40. McLane KM, Bookout K, McCord S, McCain J, Jefferson LS: The 2003 national pediatric pressure ulcer and skin breakdown prevalence survey: a multisite study. J. Wound Ostomy Continence Nurs. 31(4), 168-178 (2004).
41. Visscher MO, Chatterjee R, Munson KA, Bare DE, Hoath SB: Development of diaper rash in the newborn. Pediatr. Dermatol. 17(1), 52-57. (2000).
42. Zimmaro Bliss D, Zehrer C, Savik K, Thayer D, Smith G: Incontinence-associated skin damage in nursing home residents: a secondary ana lysis of a prospective, multicenter study. Ostomy Wound Manage. 52(12), 46-55 (2006).
43. Ouslander JG, Schnelle JF, Uman G et al.: Predictors of successful prompted voiding among incontinent nursing home residents. JAMA 273(17), 1366-1370 (1995).
44. Foureur N, Vanzo B, Meaume S, Senet P: Prospective aetiological study of diaper dermatitis in the elderly. Br. J. Dermatol. 155(5), 941-946 (2006).
45. Langoen A, Vik H, Nyfors A: Diaper dermatitis. Classification, occurrence, causes, prevention and treatment. Tidsskr. Nor. Laegeforen 113(14), 1712-1715 (1993).
46. Schnelle JF, Adamson GM, Cruise PA et al.: Skin disorders and moisture in incontinent nursing home residents: intervention implications. J. Am. Geriatr. Soc. 45(10), 1182-1188 (1997).
47. Al-Waili NS: Clinical and mycological benefits of topical application of honey, olive oil and beeswax in diaper dermatitis. Clin. Microbiol. Infect. 11(2), 160-163 (2005).
48. Berg RW: Etiologic factors in diaper dermatitis: a model for development of improved diapers. Pediatrician 14(Suppl. 1), 27-33. (1987).
49. Berg RW, Buckingham KW, Stewart RL: Etiologic factors in diaper dermatitis: the role of urine. Pediatr. Dermatol. 3(2), 102-106 (1986).
50. Berg RW, Milligan MC, Sarbaugh FC: Association of skin wetness and pH with diaper dermatitis. Pediatr. Dermatol. 11(1), 18-20 (1994).
51. Davis JA, Leyden JJ, Grove GL, Raynor WJ: Comparison of disposable diapers with fluff absorbent and fluff plus absorbent polymers: effects on skin hydration, skin pH, and diaper dermatitis. Pediatr. Dermatol. 6(2), 102-108 (1989).
52. Honig PJ, Gribetz B, Leyden JJ, McGinley KJ, Burke LA: Amoxicillin and diaper dermatitis. J. Am. Acad. Dermatol. 19(2 Pt 1), 275-279 (1988).
53. Kligman AM: Hydration injury to human skin. In: The Irritant Contant Dermatitis Syndrome. Van der Valk P (Ed.). CRC Press, Boca Ratan, FL, USA, 187-194 (1996).
54. Lee JY, Effendy I, Maibach HI: Acute irritant contact dermatitis: recovery time in man. Contact Dermatitis 36(6), 285-290 (1997).
55. Ramsing DW, Agner T: Effect of water on experimentally irritated human skin. Br. J. Dermatol. 136(3), 364-367 (1997).
56. Zimmerer RE, Lawson KD, Calvert CJ: The effects of wearing diapers on skin. Pediatr. Dermatol. 3(2), 95-101 (1986).
57. Fluhr JW, Kao J, Jain M, Ahn SK, Feingold KR, Elias PM: Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J. Invest. Dermatol. 117(1), 44-51 (2001).
58. Willis CM, Stephens CJ, Wilkinson JD: Epidermal damage induced by irritants in man: a light and electron microscopic study. J. Invest. Dermatol. 93(5), 695-699 (1989).
59. Willis CM, Stephens CJ, Wilkinson JD: Differential effects of structurally unrelated chemical irritants on the density of proliferating keratinocytes in 48 h patch test reactions. J. Invest. Dermatol. 99(4), 449-453 (1992).
60. Barany E, Lindberg M, Loden M: Biophysical characterization of skin damage and recovery after exposure to different surfactants. Contact Dermatitis 40(2), 98-103 (1999).
61. Gibbs S, Vietsch H, Meier U, Ponec M: Effect of skin barrier competence on SLS and water-induced IL-1α expression. Exp. Dermatol. 11(3), 217-223 (2002).
62. Gloor M, Senger B, Langenauer M, Fluhr JW: On the course of the irritant reaction after irritation with sodium lauryl sulphate. Skin Res. Technol. 10(3), 144-148 (2004).
63. Jensen JM, Schutze S, Neumann C, Proksch E: Impaired cutaneous permeability barrier function, skin hydration, and sphingomyelinase activity in keratin 10 de?cient mice. J. Invest. Dermatol. 115(4), 708-713 (2000).
64. Sato J, Denda M, Chang S, Elias PM, Feingold KR: Abrupt decreases in environmental humidity induce abnormalities in permeability barrier homeostasis. J. Invest. Dermatol. 119(4), 900-904 (2002).
65. Visscher M: Environmental Interactions. In: Neonatal Skin Structure and Function (2nd Edition). Hoath SB, Maibach HI (Eds). Marcel Dekker, NY, USA (2003).
66. Caplan RM: The irritant role of feces in the genesis of perianal itch. Gastroenterology 50, 19-23 (1966).
67. Ruseler-van Embden JG, van Lieshout LM, Smits SA, van Kessel I, Laman JD: Potato tuber proteins efficiently inhibit human faecal proteolytic activity: implications for treatment of peri-anal dermatitis. Eur. J. Clin. Invest. 34(4), 303-311 (2004).
68. Andersen PH, Bucher AP, Saeed I, Lee PC, Davis JA, Maibach HI: Faecal enzymes: in vivo human skin irritation. Contact Dermatitis 30(3), 152-158 (1994).
69. Borgstroem B: Influence of bile salt, pH, and time on the action of pancreatic lipase: physiological implications. J. Lipid Res. 5, 522-531 (1964).
70. Nield LS, Kamat D: Prevention, diagnosis, and management of diaper dermatitis. Clin. Pediatr. (Phila.), 46(6), 480-486 (2007).
71. Neonatal drug withdrawal. American Academy of Pediatrics Committee on Drugs. Pediatrics 101(6), 1079-1088 (1998).
72. Lainwala S, Brown ER, Weinschenk NP, Blackwell MT, Hagadorn JI: A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations. Adv. Neonatal Care 5(5), 265-272 (2005).
73. Manzoni P, Gomirato G: Effectiveness of topical acetate tocopherol for the prevention and treatment of skin lesions in newborns: a 5 years experience in a 3rd level Italian Neonatal Intensive Care Unit. Minerva Pediatr. 57(5), 305-311 (2005).
74. Ferrazzini G, Kaiser RR, Hirsig Cheng SK et al.: Microbiological aspects of diaper dermatitis. Dermatology 206(2), 136-141 (2003).
75. Lopez Martinez R, Ruiz-Maldonado R: Candidiasis in children with diaper rash. Study of 140 cases. Med. Cutan. Ibero. Lat. Am. 10(4), 225-230 (1982).
76. Patrizi A, Neri I, Marzaduri S, Fiorillo L: Pigmented and hyperkeratotic napkin dermatitis: a liquid detergent irritant dermatitis. Dermatology 193(1), 36-40 (1996).
77. Sidbury R: Nutritional dermatoses. In: Nelson Textbook of Pediatrics. Behrman RD, Kliegman RM, Jenson HB (Eds). Saunders, Philadelphia, PA, USA (2004).
78. Kuskonmaz B, Gucer S, Boztepe G, Cetin M, Uckan D: Atypical skin graft-vs.-host disease following bone marrow transplantation in an infant. Pediatr. Transplant 11(2), 214-216 (2007).
79. Elias PM, Ghadially R: The aged epidermal permeability barrier: basis for functional abnormalities. Clin. Geriatr. Med. 18(1), 103-120, vii (2002).
80. Fenske NA, Lober CW: Structural and functional changes of normal aging skin. J. Am. Acad. Dermatol. 15(4 Pt 1), 571-585 (1986).
81. Nakagami G, Sanada H, Kitagawa A et al.: Incontinence induces stratum corneum vulnerability and impairs the skin barrier function in the perianal region. Dermatology 213(4), 293-299 (2006).
82. Farage MA, Miller KW, Berardesca E, Maibach HI: Incontinence in the aged: contact dermatitis and other cutaneous consequences. Contact Dermatitis 57(4), 211-217 (2007).
83. Scheinfeld N: Infections in the elderly. Dermatol. Online J. 11(3), 8 (2005).
84. Hunter S, Anderson J, Hanson D, Thompson P, Langemo D, Klug MG: Clinical trial of a prevention and treatment protocol for skin breakdown in two nursing homes. J. Wound Ostomy Continence Nurs. 30(5), 250-258 (2003).
85. Kanj LF, Wilking SV, Phillips TJ: Pressure ulcers. J. Am. Acad. Dermatol. 38(4), 517-536; quiz 537-518 (1998).
86. Schoonhoven L, Haalboom JR, Bousema MT et al.: Prospective cohort study of routine use of risk assessment scales for prediction of pressure ulcers. Br. Med. J. 325(7368), 797 (2002).
87. Stotts NA, Wu HS: Hospital recovery is facilitated by prevention of pressure ulcers in older adults. Crit. Care Nurs. Clin. North Am. 19(3), 269-275, vi (2007).
88. Visscher, SB H: Diaper Dermatitis. In: Irritant Dermatitis. Chew A (Ed.). Springer, San Francisco, CA, USA, 37-51 (2005).
89. Schunck M, Neumann C, Proksch E: Artificial barrier repair in wounds by semi-occlusive foils reduced wound contraction and enhanced cell migration and reepithelization in mouse skin. J. Invest. Dermatol. 125(5), 1063-1071 (2005).
90. Visscher M, Hoath SB, Conroy E, Wickett RR: Effect of semipermeable membranes on skin barrier repair following tape stripping. Arch. Dermatol. Res. 293(10), 491-499 (2001).
91. Atherton DJ: The aetiology and management of irritant diaper dermatitis. J. Eur. Acad. Dermatol. Venereol. 15(Suppl. 1), 1-4 (2001).
92. Erasala GN, Merlay I, Romain C: Evolution of disposable diapers and reduction of diaper dermatitis. Arch. Pediatr. 14(5), 495-500 (2007).
93. Odio M, Friedlander SF: Diaper dermatitis and advances in diaper technology. Curr. Opin. Pediatr. 12(4), 342-346 (2000).
94. Runeman B: Skin interaction with absorbent hygiene products. Clin. Dermatol. 26(1), 45-51 (2008).
95. Campbell RL: Clinical tests with improved disposable diapers. Pediatrician 14(Suppl. 1), 34-38 (1987).
96. Campbell RL, Seymour JL, Stone LC, Milligan MC: Clinical studies with disposable diapers containing absorbent gelling materials: evaluation of effects on infant skin condition. J. Am. Acad. Dermatol. 17(6), 978-987 (1987).
97. Grove GL, Lemmen JT, Garafalo M, Akin FJ: Assessment of skin hydration caused by diapers and incontinence articles. Curr. Probl. Dermatol. 26, 183-195 (1998).
98. Seymour JL, Keswick BH, Hanifin JM, Jordan WP, Milligan MC: Clinical effects of diaper types on the skin of normal infants and infants with atopic dermatitis. J. Am. Acad. Dermatol. 17(6), 988-997 (1987).
99. Baer EL, Davies MW, Easterbrook KJ: Disposable nappies for preventing napkin dermatitis in infants. Cochrane Database Syst. Rev. 3, CD004262 (2006).
100. Adam R: Skin care of the diaper area. Pediatr. Dermatol. 25(4), 427-433 (2008).
101. Gupta AK, Skinner AR: Management of diaper dermatitis. Int. J. Dermatol. 43(11), 830-834 (2004).
102. Leyden JJ: Diaper dermatitis. Dermatol. Clin. 4(1), 23-28. (1986).
103. Wolf R, Wolf D, Tuzun B, Tuzun Y: Diaper dermatitis. Clin. Dermatol. 18(6), 657-660 (2000).
104. Shin HT: Diaper dermatitis that does not quit. Dermatol. Ther. 18(2), 124-135 (2005).
105. Gray M, Bliss DZ, Doughty DB, Ermer-Seltun J, Kennedy-Evans KL, Palmer MH: Incontinence-associated dermatitis: a consensus. J. Wound Ostomy Continence Nurs. 34(1), 45-54; quiz 55-46 (2007).
106. Gray M, Ratliff C, Donovan A: Perineal skin care for the incontinent patient. Adv. Skin Wound Care 15(4), 170-175; quiz 177-178 (2002).
107. Effendy I, Maibach HI: Surfactants and experimental irritant contact dermatitis. Contact Dermatitis 33(4), 217-225 (1995).
108. Perkins MA, Osborne R, Rana FR, Ghassemi A, Robinson MK: Comparison of in vitro and in vivo human skin responses to consumer products and ingredients with a range of irritancy potential. Toxicol. Sci. 48(2), 218-229 (1999).
109. Loden M, Buraczewska I, Edlund F: The irritation potential and reservoir effect of mild soaps. Contact Dermatitis 49(2), 91-96 (2003).
110. Ehretsmann C, Schaefer P, Adam R: Cutaneous tolerance of baby wipes by infants with atopic dermatitis, and comparison of the mildness of baby wipe and water in infant skin. J. Eur. Acad. Dermatol. Venereol. 15(Suppl. 1), 16-21 (2001).
111. Odio M, Streicher-Scott J, Hansen RC: Disposable baby wipes: efficacy and skin mildness. Dermatol. Nurs. 13(2), 107-112, 117-108, 121 (2001).
112. Visscher M, Taylor T, White T et al.: Wipes versus current standard for diaper skin care. Presented at: The National Association of Neonatal Nurses 23rd Annual Conference. San Diego, CA, USA, 26-29 September 2007.
113. Visscher M, Taylor T, White T et al.: Wipes versus Current Standard for Diaper Skin Care. Presented at: The 9th European Society for Pediatric Dermatology. Athens, Greece, 15-17 May 2008.
114. Atherton D: Maintaining healthy skin in infancy using prevention of irritant napkin dermatitis as a model. Community Pract. 78(7), 255-257 (2005).
115. Candidiasis. In: Red Book: 2003 Report on the Committee on Infectious Disease. Pickering LK (Ed.). American Academy of Pediatrics, Elk Grove Village, IL, USA, 229-231 (2003).
116. Gallup E, Plott T: A multicenter, open-label study to assess the safety and efficacy of ciclopirox topical suspension 0.77% in the treatment of diaper dermatitis due to Candida albicans. J. Drugs Dermatol. 4(1), 29-34 (2005).
117. Concannon P, Gisoldi E, Phillips S, Grossman R: Diaper dermatitis: a therapeutic dilemma. Results of a double-blind placebo controlled trial of miconazole nitrate 0.25%. Pediatr. Dermatol. 18(2), 149-155 (2001).
118. Eichenfield LF, Bogen ML: Absorption and efficacy of miconazole nitrate 0.25% ointment in infants with diaper dermatitis. J. Drugs Dermatol. 6(5), 522-526 (2007).
119. Odio MR, O'Connor RJ, Sarbaugh F, Baldwin S: Continuous topical administration of a petrolatum formulation by a novel disposable diaper. 2. Effect on skin condition. Dermatology 200, 238-243 (2000).
120. Baldwin S, Odio MR, Haines SL, O'Connor RJ, Englehart JS, Lane AT: Skin bene?ts from continuous topical administration of a zinc oxide/ petrolatum formulation by a novel disposable diaper. J. Eur. Acad. Dermatol. Venereol. 15(Suppl. 1), 5-11 (2001).
121. Food and Drug Administration, HHS: Skin protectant drug products for over-the-counter human use; final monograph. Final rule. Fed. Regist. 68(107), 33362-33380 (2003).
122. Zhai H, Maibach H: I. Barrier creams. In: Irritant Dermatitis. Chew A, Maibach H (Eds). Springer-Verlag, Berlin, Germany 435-438 (2006).
123. Hoggarth A, Waring M, Alexander J, Greenwood A, Callaghan T: A controlled, three-part trial to investigate the barrier function and skin hydration properties of six skin protectants. Ostomy Wound Manage. 51(12), 30-42 (2005).
124. Juch RD, Rufli T, Surber C: Pastes: what do they contain? How do they work? Dermatology 189(4), 373-377 (1994).
125. Honig PJ: Diaper dermatitis. Factors to consider in diagnosis and treatment. Postgrad. Med. 74(6), 79-84, 88 (1983).
126. Baatenburg de Jong H, Admiraal H: Comparing cost per use of 3M Cavilon No Sting Barrier Film with zinc oxide oil in incontinent patients. J. Wound Care 13(9), 398-400 (2004).
127. Zehrer CL, Newman DK, Grove GL, Lutz JB: Assessment of diaper-clogging potential of petrolatum moisture barriers. Ostomy Wound Manage. 51(12), 54-58 (2005).
128. Campbell JR, Zaccaria E, Baker CJ: Systemic candidiasis in extremely low birth weight infants receiving topical petrolatum ointment for skin care: a case-control study. Pediatrics 105(5), 1041-1045 (2000).
129. Wananukul S, Limpongsanuruk W, Singalavanija S, Wisuthsarewong W: Comparison of dexpanthenol and zinc oxide ointment with ointment base in the treatment of irritant diaper dermatitis from diarrhea: a multicenter study. J. Med. Assoc. Thai. 89(10), 1654-1658 (2006).
130. Arad A, Mimouni D, Ben-Amitai D, Zeharia A, Mimouni M: Efficacy of topical application of eosin compared with zinc oxide paste and corticosteroid cream for diaper dermatitis. Dermatology 199(4), 319-322 (1999).
131. Patrizi A, Neri I, Varotti E, Raone B: Clinical evaluation of the efficacy and tolerability of the "NoAll Bimbi Pasta Trattante" barrier cream in napkin dermatitis. Minerva Pediatr. 59(1), 23-28 (2007).
132. Davies MW, Dore AJ, Perissinotto KL: Topical vitamin A, or its derivatives, for treating and preventing napkin dermatitis in infants. Cochrane Database Syst. Rev. (4), CD004300 (2005).
133. Al-Waili NS, Saloom KS, Al-Waili TN, Al-Waili AN: The safety and efficacy of a mixture of honey, olive oil, and beeswax for the management of hemorrhoids and anal fissure: a pilot study. Scientific World J. 6, 1998-2005 (2006).
134. Lewis-Byers K, Thayer D: An evaluation of two incontinence skin care protocols in a long-term care setting. Ostomy Wound Manage. 48(12), 44-51 (2002).
135. Moller P, Lohmann M, Brynitz S: Cholestyramine ointment in the treatment of perianal skin irritation following ileoanal anastomosis. Dis. Colon Rectum 30(2), 106-107 (1987).
136. Senon G, Hergott C, Micard S, Rieutord A, Aujard Y, Brion F: Treatment of severe perianal cutaneous lesions in hospitalized neonates: orabase ointment interest. J. Gynecol. Obstet. Biol. Reprod. (Paris) 34(Suppl. 1), S84-S88 (2005).
137. White CM, Gailey RA, Lippe S: Cholestyramine ointment to treat buttocks rash and anal excoriation in an infant. Ann. Pharmacother. 30(9), 954-956 (1996).
138. Hayashi AH, Lau HY, Gillis DA: Topical sucralfate: effective therapy for the management of resistant peristomal and perineal excoriation. J. Pediatr. Surg. 26(11), 1279-1281 (1991).
139. Lyon CC, Stapleton M, Smith AJ, Griffiths CE, Beck MH: Topical sucralfate in the management of peristomal skin disease: an open study. Clin. Exp. Dermatol. 25(8), 584-588 (2000).
140. Visscher M: Use of a water-based skin barrier film to treat skin breakdown. Presented at: National Association of Neonatal Nurses Annual Educational Conference. Fort Lauderdale, FL, USA, 24-27 Sepetmeber 2008.
141. Wilson JR, Mills JG, Prather ID, Dimitrijevich SD: A toxicity index of skin and wound cleansers used on in vitro fibroblasts and keratinocytes. Adv. Skin Wound Care 18(7), 373-378 (2005).
142. Weston WL, Lane AT, Weston JA: Diaper dermatitis: current concepts. Pediatrics 66(4), 532-536 (1980).
143. Siegel E, Wason S: Borix acid toxicity. Pediatr. Clin. North Am. 33(2), 363-367 (1986).
144. Scheinfeld N: Diaper dermatitis: a review and brief survey of eruptions of the diaper area. Am. J. Clin. Dermatol. 6(5), 273-281 (2005).
145. Darmstadt GL, Badrawi N, Law PA et al.: Topically applied sunflower seed oil prevents invasive bacterial infections in preterm infants in Egypt: a randomized, controlled clinical trial. Pediatr. Infect. Dis. J. 23(8), 719-725 (2004).
146. Darmstadt GL, Nawshad Uddin Ahmed AS, Saha SK et al.: Infection control practices reduce nosocomial infections and mortality in preterm infants in Bangladesh. J. Perinatol. 25(5), 331-335 (2005).
147. Darmstadt GL, Mao-Qiang M, Chi E et al.: Impact of topical oils on the skin barrier: possible implications for neonatal health in developing countries. Acta Paediatr. 91(5), 546-554 (2002).
148. Tansirikongkol A, Wickett RR, Visscher MO, Hoath SB: Effect of vernix caseosa on the penetration of chymotryptic enzyme: potential role in epidermal barrier development. Pediatr. Res. 62(1), 49-53 (2007).
149. Barai N: Effect of vernix caseosa on epidermal barrier maturation and repair: implications in wound healing. In: Pharmacy. University of Cincinnati, OH, USA, 128 (2005).
150. Oudshoorn MH, Rissmann R, van der Coelen D, Hennink WE, Ponec M, Bouwstra JA: Development of a murine model to evaluate the effect of vernix caseosa on skin barrier recovery. Exp. Dermatol. DOI: 10.1111/j.1600-0625.2008.00780.x (2008) (Epub ahead of print).
151. Tansirikongkol A, Visscher MO, Wickett RR: Water-handling properties of vernix caseosa and a synthetic analogue. J. Cosmet. Sci. 58(6), 651-662 (2007).
152. Bouwstra JA, Gooris GS, Dubbelaar FE, Weerheim AM, Ijzerman AP, Ponec M: Role of ceramide 1 in the molecular organization of the stratum corneum lipids. J. Lipid Res. 39(1), 186-196 (1998).
153. Chamlin SL, Kao J, Frieden IJ et al.: Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J. Am. Acad. Dermatol. 47(2), 198-208 (2002).
154. Kucharekova M, Schalkwijk J, Van De Kerkhof PC, Van de Valk PG: Effect of a lipid-rich emollient containing ceramide 3 in experimentally induced skin barrier dysfunction. Contact Dermatitis 46(6), 331-338 (2002).
155. Huang HC, Chang TM: Ceramide 1 and ceramide 3 act synergistically on skin hydration and the transepidermal water loss of sodium lauryl sulfate-irritated skin. Int. J. Dermatol. 47(8), 812-819 (2008).
156. Al-Samarrai NR, Uman GC, Al-Samarrai T, Alessi CA: Introducing a new incontinence management system for nursing home residents. J. Am. Med. Dir. Assoc. 8(4), 253-261 (2007).
157. Padmanabhan A, Stern M, Wishin J, Mangino M, Richey K, DeSane M: Clinical evaluation of a flexible fecal incontinence management system. Am. J. Crit. Care 16(4), 384-393 (2007).
158. Stamatas GN, de Sterke J, Hauser M, von Stetten O, van der Pol A: Lipid uptake and skin occlusion following topical application of oils on adult and infant skin. J. Dermatol. Sci. 50(2), 135-142 (2008).
159. Gillespie PG, Walker RG: Molecular basis of mechanosensory transduction. Nature 413(6852), 194-202 (2001).
160. Denda M, Tsuchiya T: Barrier recovery rate varies time-dependently in human skin. Br. J. Dermatol. 142(5), 881-884. (2000).
161. Choi EH, Brown BE, Crumrine D et al.: Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity. J. Invest. Dermatol. 124(3), 587-595 (2005).
162. Aberg KM, Radek KA, Choi EH et al.: Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J. Clin. Invest. 117(11), 3339-3349 (2007).